Background Information of Panelists

                                3rd Annual Global Private Equity Conference 2002: The Year In Review & Outlook 2003
                                       Limited Partners and Private Equity Investors with over $500 Billion in Private Equity Capital Discuss Leading Trends in Buyout, Distressed Debt, Venture Capital, Media and Biotechnology Investments. Industry Leaders discuss and analyze M&A and Exit Strategies and Partnership Fund Raising. This "must attend" two-day private equity conference and deal-fest will represent over $500 billion AUM, and will showcase 7 panels, consisting of world-class Private Equity Investors, VCs, LPs, Fund of Funds, and top industry experts, as they review and summarize private equity investing, and make their predictions for 2003 and beyond. The speakers listed below have CONFIRMED:  
DATES:  

October 17th & 18th, 2002 (Metropolitan Club, New York City)
___________________________________________________________________  

DAY 1:
 


7:30 - 8:30 AM

Thursday,
October 17th, 2002
___________________________________________________________________
   
Registration and Breakfast   
___________________________________________________________________

8:30 - 9:00 AM






Welcome

   
Private Equity Investor Welcome: 
 
          James Hahn, Managing Partner, Asia Alpha Private Equity Partners

          James Hahn began his direct investment career in 1985 as a Vice President at UBS, later serving as a Senior Vice President at Prudential Securities and Merrill Lynch Asia Pacific.  James has invested globally since 1992 as a risk arbitrage portfolio manager at Alpine Alternative Assets, a Hong Kong based hedge fund.  Alpine's partners include one of China's first foreign investor.  James has been recognized by China's leadership at the Financial Reform Forum 2003 in Beijing, at APEC 2005, and at the World Economic Forum.  James is a founding shareholder of New York City commercial bank Broadway National Bank, and founding partner of Asia Alpha Private Equity, an investor in profitable high growth Chinese companies across many sectors including digital media, education, energy, financial services, communications, retail, and healthcare.   James graduated from the Wharton School of the University of Pennsylvania, is a member of Zeta Beta Tau, a member of AKA Shiba Inu Club, and supports the Parents Association of Horace Mann School.

      Keynote Speaker:

             Hardwick Simmons, Chairman & CEO, The Nasdaq Stock Market    

         Hardwick "Wick" Simmons joined The Nasdaq Stock Market, Inc., on February 1, 2001, as its Chief Executive Officer and was elected Chairman on September 26, 2001. Prior to joining Nasdaq, Simmons served as President and Chief Executive Officer of Prudential Securities Incorporated, the investment and brokerage firm, and Prudential Securities Group Inc., the firm's holding company. He is a former member of Prudential Securities' Operating Committee and Operating Council and the Prudential Securities Group Inc. Board of Directors. Prior to joining Prudential Securities in 1991, Simmons was President of the Private Client Group at Shearson Lehman Brothers, Inc. In this role, he oversaw the firm's Retail organization, which consisted of 10,500 Financial Consultants in 475 branches, as well as the Marketing and Sales and Financial Services divisions. Simmons began his career in the securities industry in 1966 when he became a Financial Advisor at Hayden Stone, a predecessor firm of Shearson Lehman Brothers, Inc. In 1969, he was named Vice President in charge of Hayden Stone's Data Processing and Communications Division and, in 1970, he became Manager of the firm's Boston office. In 1973, Simmons was appointed Executive Vice President responsible for Shearson Hayden Stone's Retail Sales and Administration. In 1977, he was named Senior Executive Vice President overseeing Marketing and Sales for Shearson/American Express. Simmons is a member and former chairman of the Securities Industry Association, a former director of the Chicago Board Options Exchange, and a former president and current member of The Bond Club of New York, Inc. He is a director and executive committee member of the New York City Partnership and Chamber of Commerce, Inc. Simmons is a member of the Board of the National Academy Foundation. Simmons is also a member of Harvard University's John King Fairbank Center for East Asian Research.Simmons graduated from Harvard University with a B.A. in 1963 and received an M.B.A. from Harvard Business School in 1966. He served in the U.S. Marine Corps Reserve from 1960 until 1966.

For more information, visit www.nasdaq.com


          

___________________________________________________________________


9:00 - 10:00 AM






Panel I   World-class Buy Out Investors Reveal Strategies For Success Under Volatile Market Conditions And      
               Describe Their Most Recent Transactions
 
    
                       
      
Panelists: 

Apollo Management, L.P

        Marc J. Rowan, Partner, Apollo Management   

      Marc J. Rowan is a founding partner of Apollo Management, L.P., a private investment partnership that manages a series of institutional funds focused on complex equity investments, leveraged buyouts and corporate reorganizations.  Prior to joining Apollo, Mr. Rowan was a member of the mergers and acquisitions department of Drexel Burnham Lambert, Incorporated, with responsibilities in high yield financing, transaction idea generation and merger structure negotiation. Mr. Rowan currently serves on several boards of directors including:  Samsonite Corporation, a leading manufacturer of luggage; Vail Resorts, Inc., the owner and operator of the Vail, Beaver Creek, Keystone and Breckenridge ski areas; Quality Distribution, Inc., the leading bulk chemical transport company in the U.S.; NRT, Inc., the leading national real estate brokerage company, National Financial Partners, Inc., a distributor of financial products to affluent individuals and small and medium sized businesses, Rare Medium, Inc., a fast growing, leading edge provider of internet e-commerce design solutions and Wyndham International, which owns, leases, manages and franchises primarily upscale and luxury hotel and resort properties.  Mr. Rowan has previously served on the board of directors of New World Communications, Inc., Furniture Brands International and Culligan Water Technologies.  Mr. Rowan is also active in charitable activities.  He is a founding member and serves on the executive committee of the Youth Renewal Fund and is a member of the board of directors of the National Jewish Outreach Program and the Undergraduate Executive Board of The Wharton School.  Mr. Rowan Graduated Summa Cum Laude from The University of Pennsylvania’s Wharton School of Business with a B.S. and an MBA in Finance.

For more information, visit www.apollolp.com


Blackstone Group 

     
Howard Lipson, Senior Managing Director, Blackstone Group  

     
Howard Lipson is a Senior Managing Director in the Private Equity group. Since joining Blackstone in 1988, Mr. Lipson has been responsible for and involved in the execution of Blackstone’s purchase of Six Flags (a joint venture with Time Warner), the acquisition of Graham Packaging, and Blackstone’s investments in Universal Orlando, Allied Waste, Volume Services America, Ritvik Toys, UCAR, US Radio and Transtar among others. Before joining Blackstone, Mr. Lipson was a member of the Mergers & Acquisitions Group of Salomon Brothers Inc. Mr. Lipson received a BS in Economics from the Wharton School of the University of Pennsylvania, where he graduated with honors. He currently serves as a Director of Allied Waste Industries, Inc., Graham Packaging, Volume Services America, Rose Hills, Ritvik Toys and Universal Orlando.

     Since 1985, without deviating from Blackstone's core beliefs, the firm has raised approximately $24 billion for alternative asset investing across its Private Equity, Real Estate, Mezzanine Financing, and Marketable Alternative Investments groups. The Mergers & Acquisitions and Restructuring & Reorganization advisory businesses have handled assignments well in excess of $350 billion. Up to December 31, 2001, Blackstone had invested total capital of $8.6 billion in 180 transactions with a total enterprise value of $72 billion through its Private Equity, Real Estate, and Mezzanine funds.

For more information, visit www.blackstone.com

                                      
Kohlberg & Company

     
Samuel P. Frieder, Principal, Kohlberg & Company

     
Samuel P. Frieder joined Kohlberg & Company in 1989 and was named a Principal in 1995. From 1988 to 1989, he was a Senior Associate in the Capital Funding Group at Security Pacific Business Credit. Prior to that, he was a Senior Real Estate Analyst at Manufacturers Hanover Trust Company. Mr. Frieder is a member of the board of directors of Airport Satellite Parking, L.L.C., Allied Aerospace Engineering, Inc., Camber Companies, L.L.C., Color Spot Nurseries, Inc., Holley Performance Products, Inc., Innotek, Inc., Katy Industries, Inc., Orion Food Systems, L.L.C., Redaelli Tecna, S.p.A, Simplicity Manufacturing, Inc., Tinnerman Palnut Engineered Products, L.L.C., and United Signature Foods, L.L.C. He is also a member of the Management Committee of Katonah Capital, L.L.C. Mr. Frieder received an A.B. from Harvard College.

    Kohlberg & Company, L.L.C. is one of the most widely known U.S. private equity firms specializing in middle market investing. Since its founding in 1987, the firm’s objective has been to realize substantial capital gains through control investments in a diversified portfolio of companies.  The firm’s goals are to increase revenues through enhanced marketing, investment in new products and selected strategic acquisitions, and to increase profitability through cost reductions and operational improvements.  The firm has completed 30 platform investments and more than 60 add-on acquisitions with an aggregate transaction value in excess of $4.0 billion.  Selected industries Kohlberg has invested in include: general manufacturing, machinery and equipment, building products, food and food related, aerospace/defense, healthcare, consumer products, automotive, and value added services.

For more information, visit www.kohlberg.com          


Morgenthaler

      
John Lutsi, Partner,
Morgenthaler

       John joined Morgenthaler in 1990, and has been active in management buyouts as an equity investor since 1986. In a career spanning three decades, John has brought to the firm an impressive balance of diverse operating experience and private equity investing. Since 1986 he has been involved in a significant number of transactions involving industrial technology and information services companies. Experienced in highly competitive industry markets for twenty years, John was a CFO and held a number of division general management positions with three New York Stock Exchange companies-IBM, Carborundum and Raymark. He has also been an adjunct professor at Fairfield University.

      As a leading management buyout and venture capital firm, Morgenthaler has worked with outstanding entrepreneurs to build world-class companies for over 34 years. The firm's goal is simple: to partner with industry-leading entrepreneurs and provide them the highest level of support possible as they build their companies. As active investors, Morgenthaler has maintained a pace of completing at least one new deal per month since January 2000. Their passion for company building has earned them the respect of their partners and exceptional results for their investors. The firm has more than $2 billion under management, including $850 million in its current fund (Morgenthaler Partners VII), which was capitalized in the summer of 2001. It has funded more than 180 companies since the firm's founding in 1968. Morgenthaler concentrates its investment activity in two areas: Its Cleveland-based buyout group focuses on traditional management buyouts and leveraged recapitalizations, industry build-ups and later-stage investments. The team invests in profitable, stand-alone middle-market companies, and divisions or subsidiaries of larger corporations. It focuses on industrial growth markets as well as the communications, services, and health care sectors. Its Silicon Valley-based venture capital team focuses on emerging technology companies. The venture group focuses on enterprise computing, life sciences, broadband communications, and semiconductor and components companies. The team is headquartered in Menlo Park, California, with satellites in Boulder, CO; Boston, MA; Dallas, TX and Princeton, NJ.

For more information, visit www.morgenthaler.com


The Carlyle Group 

    
Joe Lipscomb, Managing Director, The Carlyle Group        

     
Mr. Lipscomb is a Managing Director of The Carlyle Group, where he focuses on U.S. investment opportunities in the IT services and business outsourcing sectors. He is based in Washington, DC. Prior to joining Carlyle in 1999, Mr. Lipscomb spent seven years in the Technology Investment Banking and Leverage Finance Group at BT Alex. Brown where he was responsible for IT services investment banking. Prior to his work with BT Alex. Brown, Mr. Lipscomb was in the High Yield Group at First Boston. Mr. Lipscomb is a graduate of Kenyon College, the Wharton Graduate School of Business, and the Johns Hopkins School of Advanced International Studies.

      Established in 1987, The Carlyle Group is a private global investment firm that originates, structures and acts as lead equity investor in management-led buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. Since its inception, the firm has invested more than $6.6 billion of equity in 247 corporate and real estate transactions with an aggregate acquisition value of over $18 billion. As of March 31, 2002, the firm had more than $13.5 billion of committed capital under management. Carlyle’s extensive transaction experience and network of global partners are sources of corporate opportunities unparalleled in the private equity investment community. Headquartered in Washington, DC, the firm serves a diverse base of more than 535 investors in 55 countries worldwide.

For more information, visit www.thecarlylegroup.com

                            
Moderator/Limited Partner:

Office of The New York State Comptroller  
         
      Paula Chester, Director of Private Equity, Office Of The New York State Comptroller  
          

     Paula L. Chester, has served as Director of Private Equity in the office of the New York State Comptroller, since February, 1999. Prior to her appointment, Ms. Chester served as Counsel to the Comptroller of the State of New York for five and a half years.   Born in Baltimore, Maryland, Ms. Chester received her undergraduate degree in music from the University of Michigan in 1968.  She received an MS degree from Morgan State University in 1972 and a JD degree from the University of Maryland School of Law in 1977.  She is admitted to practice law before the Maryland and the New York State Bars.  

      The Comptroller is the chief fiscal officer of the State of New York, the administrative head of the State and Local Retirement Systems, and the sole trustee of the State’s Common Retirement Fund with assets of $112 billion.  As Counsel, Ms. Chester was responsible for the supervision of the division of Legal Services which has 35 attorneys and 23 support staff who serve the Comptroller in a variety of capacities. As the Common Retirement Fund’s Director of Private Equity, Ms. Chester oversees a portfolio of over $15.8 billion in Alternative Investments and Opportunistic Real Estate.  The portfolio includes venture capital, corporate finance, special situation, and international funds as well as certain pooled real estate transactions.

      Prior to her appointment as Counsel to the Comptroller, Ms. Chester served as general counsel to the New York City Comptroller from 1990-1993.  Before joining the City Comptroller’s Office, Ms. Chester served as an associate and later partner in the firm of Berger & Steingut.  Between 1977-1981, she worked for the U.S. Securities and Exchange Commission – first as a branch attorney in the Division of Corporate Finance; then as a special counsel of the SEC’s Office of Small Business Policy.  Ms. Chester is the author of Regulation D, promulgated under the Securities Act of 1933.

For more information, visit www.osc.state.ny.us

___________________________________________________________________


10:00 - 10:30 AM


Q&A 

___________________________________________________________________

10:30 - 11:30 AM



Panel II  The World's Leading Biotechnology And Life Science Investors Describe Their Investment Process,
                 Analyze Deal Opportunities And Highlight Sectors With The Most Potential For Growth

Panelists: 

Atlas Venture

     
Peter Barrett, Partner Atlas Venture

      Peter Barrett joined Atlas Venture in 2002. Previously, he was a co-founder and former Executive Vice President and Chief Business Officer of Celera Genomics, positions he had held since 1998. Within two years of the founding of the company, Celera announced the first successful sequencing of the human genome. At Celera, Peter helped launch the company as a publicly traded entity in 1999 and helped transform Celera into a leading force within the biotechnology industry, with annual revenues of over $100 million. He led Celera’s expansion into drug discovery and development, forging strategic alliances with technology companies and leading the acquisition of Axys Pharmaceuticals. Before Celera, Peter held senior management positions at The Perkin-Elmer Corporation, most recently serving as Vice President, Corporate Planning and Business Development. During his tenure, he expanded the life science business units through a series of licensing agreements, partnerships and acquisitions including: Applied Biosystems, Tropix, Molecular Informatics, PerSeptive Biosystems, and Genscope. Also during this time, Peter co-founded Celera Genomics with Dr. J. Craig Venter and the Applera Corporation management team. Additional managerial roles included Executive Vice President of the Applied Biosystems Division of Perkin-Elmer. Peter received his Bachelor of Science in chemistry from Lowell Technological Institute (now known as the University of Massachusetts, Lowell) and his Ph.D. in analytical chemistry from Northeastern University. He also completed Harvard Business School’s Management Development Program. Peter currently serves as a board member of HuBit Genomix and Genecore. Prior board appointments include Chairman of the Board of the Analytical and Life Science System Association, Roche Strategic Alliance, and Sciex Joint Venture.

     Atlas Venture is the leading international early-stage venture capital firm, investing in communications technology, information technology and life sciences companies.  With investing offices in Boston, London, Menlo Park, Munich, Paris and Seattle, Atlas Venture divides its investments between the United States and Europe. Founded in 1980, Atlas Venture has organized six international funds, and currently manages $2.4 billion in committed capital.  The Atlas Venture investment team is comprised of seasoned operating executives and career venture capitalists who have been deeply involved in the formation and development of more than 300 companies worldwide. 

For more information , visit  www.atlasventure.com.



Boston Millennia Partners

        Dr. Rob Mashal, PartnerBoston Millennia Partners

        Rob focuses on Life Sciences opportunities, primarily drug discovery and development and enabling technologies for the drug development process, including genomics, systems biology, and chemical genomics. Prior to joining Boston Millennia Partners, Rob was a Program Executive for the MDR program at Vertex Pharmaceuticals (Nasdaq: VRTX). He was also a member of the Joint Research Committee for the $800 million Vertex-Novartis kinase collaboration. At Vertex, Rob gained extensive experience in overseeing drug discovery and development programs, and implementing strategic business partnerships. Prior to joining Vertex, Rob was an associate at McKinsey & Co. where he advised a variety of clients in the healthcare/life sciences industries. Before that, he was an attending physician at the Dana-Farber Cancer Institute where he conducted research on molecular genetics. He did his internal medicine residency at the University of California, San Francisco and completed his medical oncology fellowship at the Dana-Farber Cancer Institute. He holds a B.A. and M.D. from Johns Hopkins University.

        Boston Millennia Partners provides private equity financing to high growth companies in the telecommunications, information technology, and healthcare and life sciences industries. Our team brings over seventy-five years of combined private equity experience to the investment process. Our broad experience, combined with expertise in finance, engineering, operations, and law provides significant value to the companies in which we invest. Over the past twenty years, we have developed an investment approach that centers on active participation with our portfolio companies. Our goal is to be valuable and effective investors while at the same time establishing productive relationships with our business partners that create long term value. We seek to partner with entrepreneurs who share our goal of building enduring, large-scale businesses. Our history reflects an entrepreneurial spirit that has guided our investment philosophy since 1979. The growth and success of our portfolio companies have, in turn, allowed us to grow and expand our present capital base to over $700 million. As our firm has grown, we have built a network that spans the globe. Investors from a dozen countries have entrusted us to manage capital on their behalf

For more information, visit www.millenniapartners.com 


JP Morgan Partners

        Dr. Srinivas Akkaraju, Principal, JP Morgan Partners

        Srinivas joined the Life Sciences team in the Healthcare Group at JPMorgan Partners, LLC in April '01. From October '98 to April '01, Srinivas was in Business and Corporate Development at Genentech, Inc., most recently as Senior Manager. There he was responsible for worldwide partnering activities including technology access deals, in-licensing of early and late-stage therapeutics, and out-licensing of Genentech development projects. In addition to his business development role, Srinivas also served for the last year as Project Team Leader for one of Genentech's clinical development products. During this time, Srinivas was also a founding member of BioStreet, an online marketplace for biotech opportunities. Prior to joining Genentech in 1998, Srinivas was a graduate student at Stanford University, where he earned his M.D. and Ph.D. in Immunology. Srinivas earned his undergraduate degrees in Biochemistry and Computer Science from Rice University in 1990. He is currently a Director of Eyetech Pharmaceuticals.

        JPMorgan Partners ("JPMP") is a global private equity organization which provides equity and mezzanine capital financing primarily to private companies. We invest throughout the entire life cycle of the business development process. Our investment mandate permits maximum flexibility in supporting the equity needs of businesses worldwide. JPMP strives to be management's partner of choice. JPMP complements management in their pursuit to expand globally, consolidate industries, enhance technology, access financing markets in the most efficient manner and build and maintain top personnel. With over 150 investment professionals, JPMP invests globally. JPMP currently manages an $31 billion portfolio which includes $20 billion of direct equity and mezzanine investments. JPMP also manages $11 billion of other alternative assets and high yield/leveraged loan products. Since our inception in 1984, JPMP has closed more than 1,800 direct equity and mezzanine transactions. JPMP's diversified portfolio includes board seats in over 300 companies. JPMP's primary limited partner is J.P. Morgan Chase & Co., a leading global financial services firm with assets of $741 billion and operations in more than 50 countries. Other prominent institutions and individuals are also investors in JPMP.

For more information, visit www.JPMorganPartners.com


Perseus-Soros Biopharmaceutical Fund

       Dr. Drew Schiff, Managing Director, Perseus-Soros Biopharmaceutical Fund

      
Dr. Schiff joined Perseus-Soros in September of 1999 and currently serves as a Managing Director. Over the last 10 years, Dr. Schiff has practiced internal medicine at The New York Presbyterian Hospital where he maintains his position as a Clinical Assistant Professor of Medicine. In addition, he has also been a partner of a small family run investment fund, Kuhn, Loeb & Co. Dr. Schiff received his MD from Cornell University Medical College and his MBA from Columbia University. His bachelor’s degree in neuroscience was awarded with honors by Brown University. He currently serves on the board of directors of Adams Laboratories, Barrier Therapeutics, Bioenvision, and Myogen.

        Perseus-Soros Biopharmaceutical Fund was established in 1999 by affiliates of Perseus, L.L.C. (Perseus) and Soros Private Funds Management, LLC (SPFM) to make investments in life science companies developing biopharmaceutical products and creating businesses based on advanced life science technologies. Perseus, L.L.C. is a merchant back and private equity fund management company headquartered in Washington, D.C. operating funds with over $1 billion of private capital. Perseus has extensive experience in structuring financial investments. Perseus' funds include Perseus 1996, Perseus Capital, Perseus 2000, and the Perseus Acquisition/Recapitalization Fund. Perseus also has extensive investment effort in advanced technologies in the energy field. SPFM is an affiliate of Soros Fund Management, L.L.C. (SFM) based in New York and London. The Soros organization has been one of the world’s most successful investors during the past 21 years in a variety of markets, securities, investment vehicles (including private equity), and industries in more than 45 countries.

For more information, visit www.psbiofund.com


Sprout Group

     
Ron Hunt, Partner, Sprout Group

    Ron Hunt is a partner at the Sprout Group and joined the firm in early 1998. His focus is early and later stage investments in life sciences and health care technologies. Prior to joining Sprout, Ron was a consultant with Coopers & Lybrand Consulting and The Health Care Group for a combined 4 years. His consulting work focused on strategic and operational engagements for clients in the pharmaceutical, medical device, and health care services industries. Prior to entering the consulting field, Ron held a number of sales and marketing positions for a combined 8 years with Johnson & Johnson and SmithKline Beecham Pharmaceuticals. Ron is a graduate of The Wharton School (MBA) and Cornell University (BS).

        Since raising our first venture fund of $12 million more than 30 years ago, Sprout has invested in more than 350 companies whose combined revenues now exceed $50 billion. Our current fund, Sprout Capital IX, totals $1.6 billion. Sprout is committed to building a portfolio that is foucsed on technology investments and is balanced by stage and industry, including early stage, growth, mezzanine, and buyout investments in the Datacom & Telecom, E-Commerce, Services, Healthcare Technology, Software and Technology industries. While we are not typically providers of seed capital, Sprout is very active as early stage investors. Sprout Capital IX was raised in late 2000, and is $1.6 billion.  The fund is capitalized primarily by commitments from large corporate pension funds, public funds, insurance companies, endowments, and other private investors - 60% of whom have invested in previous Sprout funds. Our roster of limited partners includes AIG, Brinson Partners, The Common Fund, Equitable Life, Harbourvest, St. Paul Fire & Marine, and Toronto Dominion Bank, as well as the pension funds of BP(ARCO), Honeywell, the states of Michigan, Virginia, Washington, and others.

For more information, visit www.sproutgroup.com


        
Moderator/Limited Partner:

Invesco Private Capital   

      
Mary Frances Kelley, General Partner,
Invesco Private Capital 

      Mary Frances Kelley, General Partner, is a nationally recognized small business expert and lecturer, and has been a consultant to two Fortune 100 financial services firms. Mary joined Sovereign Financial Services (now INVESCO Private Capital) in 1994. She began her career in 1976 with Deloitte & Touche in the Audit and General Service department. Mary founded her own full service accounting firm in 1980. Her business acumen and leadership have been recognized by both the Reagan and Clinton administrations. She was a participant in President-elect Clinton’s Economic Summit, and has served on an advisory board to the Kansas City Federal Reserve Bank. She was one of eleven commissioners for the White House Conference on Small Business in 1995. She has extensive experience in business valuation and strategic planning matters. In addition, she has worked with a number of businesses, foundations and endowments with regard to the development of systems, reporting and internal controls. Mary serves on several partnership advisory boards including Telecom II & III, CHL Medical, Healthcare Ventures and Apex. She received a B.A. in Secondary Education from the University of New Mexico in 1971. Her business and civic leadership include a term as the national president of the National Association of Women Business Owners. Mary served on the Board of the National Federation of Independent Business, this country’s largest small business organization (600,000 members) with a presence in all 50 states from 1988 to 1998. She is a licensed Certified Public Accountant in the State of Colorado.

For more information, visit www.invescoprivatecapital.com/pvtcap/main.html

___________________________________________________________________


11:30 - 12:00 Noon


Q&A    

___________________________________________________________________

12:00 Noon - 1:00 PM


Panel III 
Global Media & Communications Titans Discuss
Investment Opportunities In High Growth Media Industry Segments, Including Broadcasting, Cable & Entertainment,  Publishing, Information Services, and Digital Rights Management

Panelists:

Allen & Company

      John Griffen, Director, Allen & Company

     John Griffen heads the private equity and underwriting businesses at Allen & Company, and in that capacity is responsible for identifying interesting investment and capital raising opportunities with emerging private companies.  Allen & Company is a closely-held investment bank in New York City specializing in finance for media, communications, and technology companies.  The firm hosts an annual conference for corporate leaders in Sun Valley, and has recently worked with companies such as USA Networks, Vivendi, BET, and News Corporation, among others. Before joining Allen & Company, Mr. Griffen was a Managing Director with Bankers Trust in London.  He was also a founder and Managing Director of the G7 Group, a financial advisory and publishing firm providing forecasts of global capital markets for leading hedge funds, investment banks, and other financial institutions.  Mr. Griffen has also held several senior economic policymaking jobs in Washington with the House Ways and Means Committee, House Budget Committee, and Office of Management and Budget. Mr. Griffen received his undergraduate degree from Haverford College, his MPA from Princeton University, and his MBA from the Wharton School at the University of Pennsylvania.


Global Technology Investments

       Michael Schulhof, President,
Global Technology Investments

     Michael P. Schulhof is a private investor focused on high technology, new media and internet companies.  He serves as a director on the boards of a number of the companies in which he has investments, including CBS/Sportsline USA, an online media service devoted to sports news and information, J2 Global Communication, an internet-based unified messaging company, and Global Technology Investments, a venture company specializing in the commercialization of high tech innovations. Mr. Schulhof is a former trustee of Lincoln Center for the Performing Arts, Inc. and Brandeis University, and currently on the Board of New York University/Mt. Sinai Medical Center, International Tennis Hall of Fame, and the Brookings Institution.  He also serves on the board of directors of the Center on Addiction and Substance Abuse at Columbia University, The American Hospital of Paris Foundation, and is a member of the Council on Foreign Relations. Mr. Schulhof’s thorough understanding of the technology-driven media, communications and entertainment industries is a result of his training as a scientist and his work with Sony’s Akio Morita in the development and implementation of business strategy for Sony that focused on technology based consumer products and entertainment content.  From 1990 to 1995, Mr. Schulhof was president and chief executive officer of Sony Music Corporation, and from 1993 to 1995 he was president and chief executive officer of Sony Corporation of America. Dr. Schulhof received his B.A. from Grinnell College (1964); M.S. from Cornell University (1967); Ph.D. from Brandeis University (1970); and received an Honorary Degree as Doctor of Physics from Grinnell College.


Quadrangle Group

      Josh Steiner, Managing Principal, Quadrangle Group

      Joshua L. Steiner is a founding Managing Principal of Quadrangle Group LLC, a private investment firm specializing in the media and communications industries.  In this capacity, Mr. Steiner is responsible for sourcing, executing and monitoring portfolio investments and he serves on the board of Pathfire, Inc., a portfolio company. Prior to the formation of Quadrangle Group in March 2000, Mr. Steiner was a Managing Director at Lazard Frères & Co. LLC, where he was a member of the firm’s Media and Communications Group and worked on advisory and financing assignments for clients in various industries including electronic and print publishing, television and radio broadcasting, telephony and data communications, online distribution and content, and cable, wireless and satellite video distribution and programming. While at Lazard, Mr. Steiner’s clients included American Media, CMP Media, Comcast Corporation, Harcourt General, Infogrames Entertainment, Polygram and Time Warner. Prior to joining Lazard, Mr. Steiner was the Chief of Staff for the United States Department of the Treasury, where he was responsible for managing the Secretary of Treasury’s staff and served as his adviser on domestic and international policy as well as management and communications issues. Mr. Steiner serves on the Board of Trustees of the New York Public Library and he is co-Chair of the Executive Committee of the Enterprise Foundation of New York, an organization that helps develop and maintain affordable housing.  In addition, he serves on the Boards of the International Center for Ethics, Justice and Public Life, the Andover Development Board and the Hebrew Free Loan Society.  Mr. Steiner is a member of the Council on Foreign Relations where he is on the Board of Advisors of Foreign Affairs.  Mr. Steiner received a M.St. in Modern History from University College, Oxford University, where he received Special Commendation from the Board of Examiners.  He received a B.A. in History from Yale University. 

      Quadrangle Group LLC is a private investment firm that invests in the global media and communications industries. Quadrangle looks to partner with superior management teams in companies where our experience, relationships and capital can help create long-term value. We invest across much of the maturity spectrum -- from growth to fully developed companies - primarily in North America and Europe although we will consider investments in other regions on an opportunistic basis. We look to invest $20 million to $150 million of capital in each transaction and with co-investments from certain of our limited partners, have the capacity to invest considerably more.  With decades of collective experience advising and investing in the media and communications industries, Quadrangle's Team has an extensive network of relationships with leading companies, executives and entrepreneurs. The depth and quality of these relationships is illustrated by the firm's Advisory Board and by the firm's investor group that includes more than 50 current and former senior executives of leading companies in the media and communications fields. Quadrangle seeks to generate superior returns through its disciplined investment approach, which focuses on sound businesses that will benefit from the firm's extensive experience and relationships.

For more information
, visit www.quadranglegroup.com



Veronis, Suhler, Stevenson

       James P. Rutherfurd, Executive Vice President,
Veronis, Suhler, Stevenson 

       James P. Rutherfurd
heads the Investment Banking Group of Veronis Suhler Stevenson, is an Executive Vice President and Managing Director of  VSS and a Senior Principal of  the Fund.  Mr. Rutherfurd is also a member of the VSS Executive Committee.  Mr. Rutherfurd manages the VSS Focus Program with a mandate to originate transactions for the Fund, the Equity Funds and the investment bank by leveraging firm-wide resources.  Mr. Rutherfurd joined VSS in January 1999 from JP Morgan & Co., where he served as a Managing Director in the Mergers & Acquisitions Group and Co-Head of JP Morgan's Media Group.  He was previously a Director in The First Boston Corporation's Media Group.  Mr. Rutherfurd has closed more than $28 billion in Media industry transactions including advisory engagements, equity and debt underwritings, equity swaps and syndicated bank loans.  His clients range across many segments of the Media industry, including newspapers, television, cable, magazines, radio, information services, Internet services and entertainment.  Mr. Rutherfurd holds a JD from the University of Virginia School of Law and a BA from Princeton University.

        VS&A Communications Partners makes direct investments in the media, communications and information industries through its private equity funds - VS&A Communications Partners II, L.P. (Fund II) and VS&A Communications Partners III, L.P. (Fund III). Fund III was capitalized at $1.017 billion in 1999. Many of Fund III's limited partners, which include endowments, domestic and international corporations and their pension funds, and government-sponsored pension funds, invest with VS&A Communications Partners because of the unique vantage point it commands among a diverse set of communications industries. This vantage point enables it to provide our partners with access to proprietary deal flow and co-investment opportunities across all communications industry segments. Few private equity firms specialize in communications; fewer still cover as many industry segments as VS&A Communications Partners. This broad coverage reduces investment risk through diversification.  Fund III seeks businesses that can achieve growth through strategic acquisitions and/or expansion opportunities. 

For more information, visit www.veronissuhler.com.

     
Moderator:   


Heller Ehrman

        
Guy Molinari, Partner, Heller Ehrman         

         Prior to joining the firm, Mr. Molinari was a partner at Werbel & Carnelutti. Mr. Molinari has practiced business law since 1987, with an emphasis on corporate finance, securities and mergers and acquisitions. Mr. Molinari ‘s practice focuses on representation of entrepreneurs, developing businesses, financial intermediaries and private and institutional investors. Transactional representation includes most phases of development: financing, whether in public or private, equity or debt markets; going public; business combination transactions; going private; and contests for corporate control. Mr. Molinari received his degrees from the University of Pittsburgh (B.A., summa cum laude, Phi Beta Kappa) and Columbia Law School and Columbia Business School (J.D./M.B.A.,).

         Helping clients shape the new economy is the primary mission of lawyers at Heller Ehrman. As a full-service firm representing clients from the largest publicly traded companies to emerging private enterprises, the breadth and quality of service we provide is unmatched by our competitors.  Our offices are located in San Francisco, Silicon Valley, Los Angeles, San Diego, Seattle, Portland, Anchorage, New York, Washington, D.C., Montgomery Co., MD, Hong Kong and Singapore. At 544 lawyers, we are one of the fastest growing firms in the country. Heller Ehrman lawyers service clients throughout the biotech, telecommunications, securities, banking and computer industries. Within 15 national practice groups, our lawyers are leaders in some of today’s hottest practice areas, including intellectual property, life sciences, antitrust, mergers and acquisitions and emerging companies. We have a tradition of service that extends not only to paying clients but to communities and to individuals who cannot afford much needed legal services. Firmwide, Heller Ehrman attorneys contribute thousands of hours each year to community, nonprofit and public interest organizations—dedication that earned us the American Bar Association’s 2000 Pro Bono Publico Award.  As we move into the new millennium, we will expand our services and continue the traditions we began more than a century ago. Our attorneys will carry forward proudly their commitment to client services, the legal profession and the public interest as a whole. 

For more information, visit www.hewm.com.


_________________________________________________________________


1:00 - 2:00 PM


Luncheon 

___________________________________________________________________

2:00 - 3:00 PM


Panel IV  Premier Venture Capitalists Reveal Their Recent Investments & Identify Sectors For Growth For 2003 
    
Panelists: 

ABS Capital Partners

       Dean Goodermote, Partner, ABS Capital Partners

      Dean joined ABS in 2001 as a Venture Partner to work closely with portfolio companies in the software and services space. With over 15 years of senior management experience, he has led a number of technology companies through their expansion stages. Before joining ABS, Dean was the CEO of ABS portfolio company Clinsoft (formerly Domain Pharma), a leader in clinical trial and biopharmaceutical information platforms. Dean was instrumental in re-focusing the company's strategy and growing revenues. In August 2001, Clinsoft merged with Phase Forward to create the dominant software company for clinical development. Prior to Clinsoft, Dean was the CEO of Process Software, a developer of Internetworking software, where he increased revenues and launched the company's key new product. During this time, he also served as Chairman and President at Domain Solutions Corporation. Before that, as President and Chairman of PSDI, now called MRO Software, he led the company through a successful IPO and secondary offering.
        ABS Capital Partners was founded in 1990 to invest in mid- to later- stage companies with scalable, sustainable business models that create long-term value. The firm's investment strategy focuses on companies providing software, services and infrastructure to Global 2000 corporations, healthcare enterprises and media/communications companies. ABS Capital leverages over 100 years of combined experience among its partners, and offers a range of investment structures, including expansion financings, management buyouts and recapitalizations for growth companies. The partners' extensive knowledge of equity capital markets allows them to provide strategic guidance to companies and establish them as significant market leaders. With $1.4 billion under management, ABS has seven investing partners, and has offices in Baltimore, San Francisco and Northern Virginia. Over the past ten years, ABS Capital has invested in over 60 portfolio companies, including Transaction System Architects, Inc (NASDAQ: TSAI), DoubleClick, Inc (NASDAQ: DCLK), SBA Communications Corporation (NASDAQ: SBAC), AMISYS Managed Care Systems Corporation (now McKesson HBOC) (NYSE: MCK) and OTG Software, Inc. (NASDAQ: OTGS).

For more information, visit www.abscapital.com


Crimson Ventures

       John-Paul Ho, Partner, Crimson Ventures

    
   John-Paul Ho is the founder of Crimson. John-Paul led Crimson’s investments in Timogen, Polivec, @Road, TransMedia and Transmeta, amongst others. He was previously in charge of the technology investment banking efforts of CS First Boston throughout Asia, and was also a Vice President in the technology investment-banking group in New York. He was also previously a member of the Mergers and Acquisitions department of Goldman Sachs. John-Paul received an MBA from Harvard Business School, where he graduated with distinction and was awarded a Dean's Doctoral Fellowship. He also received an undergraduate degree in Engineering and Applied Sciences from Harvard University, where he graduated summa cum laude and was elected Phi Beta Kappa.

     Crimson is a private equity firm headquartered in Silicon Valley with over $500 million under management. Crimson @Velocity invests in U.S. and Pacific Rim companies that enable Global 1000 corporation to reduce costs and improve operational efficiencies. We focus on investments in enterprise software, outsourced services and manufacturing, infrastructure systems, components and semiconductors. We have an active presence in the US and throughout the Pacific Rim. We leverage our entrepreneurial and operational experience in technology to help build companies in the U.S. and Asia. Crimson helps companies to strengthen business strategies, build management teams, and access customers and strategic partners. Our capabilities enable us to help grow successful companies and position them in public markets.

For more information, visit www.crimsonventures.com


                                       
General Atlantic Partners

       
Drew Pearson, Principal,
General Atlantic Partners

        Drew Pearson is a Principal at General Atlantic Partners, LLC, a worldwide private equity firm, where he has worked since 1996. Mr. Pearson is based in Greenwich, CT and concentrates on portfolio company support. Mr. Pearson has worked on over $150 million in transactions in the Enterprise Software and IT Infrastructure markets, including Manugistics, EXE Technologies, and Talus Solutions. Prior to joining General Atlantic Mr. Pearson was a business analyst with McKinsey & Company, Inc. where he worked with Fortune 500 businesses in the technology and financial services industries. Mr. Pearson holds a MA/BA in Regional Science from The School of Arts & Sciences at the University of Pennsylvania, and a BS in Finance from The Wharton School at the University of Pennsylvania.      
  
        General Atlantic Partners, LLC focuses exclusively on equity investments in information technology and communications businesses globally.  Founded in 1980, the firm has over $4 billion of capital available for investment and has invested in more than 120 companies.  Almost one-third of the firm’s 70 current portfolio companies are based in Europe, Asia or Latin America.   Current holdings include Apollis, digiquant, E*TRADE Group, Inc., Eclipsys, Exact, EXE Technologies, Exult, Firepond, iDNS, iFormation Group, Manugistics, Predictive Systems, ProBusiness, Rebus, Screaming Media, SESA, Upromise, Xchanging and Zagat. The firm is distinguished within the investment community by its deep experience and expertise in information technology, global perspective and worldwide presence, long-term approach to investments, and commitment to provide sustained strategic assistance for its portfolio companies.  General Atlantic has 75 professionals located in Greenwich, New York, Palo Alto, Reston, London, Düsseldorf, Singapore, Tokyo, Hong Kong, and São Paulo.  

For more information, visit www.gapartners.com.


New Enterprise Associates

        Harry Weller, Partner, New Enterprise Associates
         

      Harry joined NEA in January 2002 as a partner. He specializes in information technology companies focusing on enterprise software, infrastructure and applications. Prior to joining NEA, Harry was a partner at FBR Technology Venture Partners where he worked primarily with enterprise software companies. Previously, Harry was with the Boston Consulting Group and Deloitte & Touche Management Consulting. At both firms, he managed strategy and technology initiatives in the financial, manufacturing and telecommunications industries. In particular, he specialized in leading teams through the sales, selection and implementation of large-scale enterprise software projects. Harry received a Masters in Business Administration from Harvard School of Business Administration and a Bachelor of Science in Physics from Duke University.

        Founded in 1978, NEA has grown to eleven partnerships managing $5 billion of capital.  We are classic venture capital investors, concentrating on early stage companies in the areas of information technology and medical and life sciences.  We typically invest in 20 to 30 new companies each year.  Our first investment can be as little as $200,000 or up to $20 million, and we typically support our companies through multiple rounds of financing.

For more information, visit www.NEA.com


Wasserstein Ventures
  

        W. Townsend Ziebold, Jr., President, Wasserstein Ventures  

          W. Townsend Ziebold, Jr. is President of Wasserstein Ventures.
Mr. Ziebold played a leading role in several of Wasserstein & Co.'s investments, including Digital River, Loudeye, <kpe>, Venetec, Firekey, PlanSoft, eMotion (fka Cinebase Software), Pulse and Salon.com, for many of which he sits on the board of directors. Mr. Ziebold is also a director and Non-executive Chairman of Imax Corporation, a leading large-screen film projection company, and a former director of Collins & Aikman Corporation, a $2 billion sales diversified manufacturing company, and Maybelline, Inc., a leading mass market cosmetics manufacturer. Mr. Ziebold received his B.A. in Economics from Trinity College and his M.B.A. from the Stanford School of Business. Mr. Ziebold currently serves as a member of the Board of Fellows of Trinity College and as President of the Board of Trustees at West Side Montessori School in New York City.

        Wasserstein Ventures
is the venture capital affiliate of Wasserstein & Co., LP, a leading international private equity investment firm with over $1.5 billion in assets under management.  Wasserstein Ventures strives to maximize the value of its knowledge and relationship base by investing with a purposeful philosophy in carefully selected strategic theses. Currently Wasserstein Ventures focuses on early-stage venture investment opportunities in networking and communications companies, specifically in the areas of optics, wireless, semiconductors, digital media and Internet infrastructure technologies. The principals of Wasserstein Ventures bring over 55 years of operational and financial expertise to bear in working with premier entrepreneurs to help build industry-leading high growth companies. Wasserstein Ventures works to develop alliances between portfolio investments and a broad-based global network of strategic and financial relationship partners. Wasserstein Ventures has to date invested over $110 million in more than 30 companies.  Wasserstein Ventures has offices in New York, San Francisco, Los Angeles and Palo Alto.

For more information, visit www.wasserco.com
                    
 
           
Moderator:


       James Hahn, Chairman, Global Venture Network, & Partner, Alpine Venture Associates
___________________________________________________________________



3:00 - 4:00 PM




Panel V 
Private Equity Buyout Experts And Venture Capitalists Compare And Contrast  Exit Strategies: Buyouts,  Roll-ups, And The Return Of The IPO Markets

Panelists: 

Bear, Stearns & Co.

      
Edward Rimland, Senior Managing DirectorBear, Stearns & Co.

       Mr. Rimland is a Senior Managing Director in the New York office and the senior member of Bear Stearns’ Mergers and Acquisition Group with responsibility for the Technology sector. He is also a member of the firm’s Valuation Committee which is responsible for reviewing all of the firm’s fairness opinions. He joined Bear Stearns in 1992, after spending five years in the Mergers and Acquisition Department of Morgan Stanley & Co. Incorporated. Over the past fifteen years, he has been involved in the strategic and tactical analysis of a wide variety of M&A transactions, including domestic and international acquisitions (public and private), exclusive sales, joint ventures and takeover defense with an aggregate value in excess of $100 billion. Further, his transaction experience encompasses a wide variety of subsectors in technology including aerospace/defense, software, information services, semiconductors and telecom equipment. Mr. Rimland received a B.A.S. and a B.S. from the Wharton School at the University of Pennsylvania and an M.B.A. from the Darden School at the University of Virginia.

For more information, visit  www.bearstearns.com


M.D. Sass & Co. 

       
Hugh R. Lamle, President, M.D. Sass & Resurgence Asset Management

       Hugh R. Lamle is President of M.D. Sass Investors Services, Inc., a registered Investment Advisor, whose clients include substantial pension and profit sharing funds, insurance companies, Nuclear Decommissioning Trusts, endowment and charitable funds, major corporations and substantial individual portfolios, and foreign investors' portfolios. Mr. Lamle is also President of Re/Enterprise Asset Management and Resurgence Asset Management. Re/Enterprise manage distressed securities portfolios for partnerships and separate accounts in a liquid “hedge fund” format. Resurgence manages control oriented distressed portfolios in a “private equity” fund. At M.D. Sass, he is responsible for the formulation of investment policy and strategy, directing the firm's management of debt securities portfolios, hedged equities and directing the firm's research on options, financial futures, financial analysis models, applications of quantitative analysis for investment research and portfolio management and the development of alternative investment strategies.  From 1995 to 2001, Mr. Lamle was also President, Chief Investment Officer and Chief Executive Officer of Chase & MD Sass Partners, a joint venture between The Chase Manhattan Bank and M.D. Sass Investors Services, Inc. Chase & MD Sass Partners managed cash, short and intermediate term portfolios for Chase and corporate and institutional clients as well as a broad range of non-Chase related corporate, financial institution, government, charitable and high net worth individuals.  Mr. Lamle serves on the Partnership Board of Real Estate Capital Partners (RECAP). RECAP is a joint venture affiliate of M.D. Sass and invests in net lease, development and special situation real estate. He is was formerly Vice Chairman of the Board of Directors of the FINEX (a regulated Commodities Exchange)He is a Public Director of the New York Board of Trade (a regulated Commodities Exchange) and a member of the Board of Directors of Quelsys (a privately owned educational software company) and a Director of Coolsavings Inc. (the leading provider of incentive marketing promotions on the internet). 

        Prior to joining M.D. Sass in 1974, he was responsible for founding Lenox Capital Management, the investment advisory affiliate of duPont Glore Forgan. Prior to Lenox Capital Management's formulation, he managed the partner's capital for Francis I. duPont (which, at that time, was the third largest brokerage firm in the US). He is a member of the New York Society of Security Analysts, the New York Institutional Options Society, the International Association for Financial Engineers, an honorary member of Beta Gamma Sigma (the national academic honor society for business degree students), and is a Fellow in the Financial Analysts Federation. He is also a Trustee of the Citizens Budget Commission. He has lectured frequently at universities and professional forums on investments and has authored numerous articles on investments for professional journals.He is frequently quoted in newspapers and magazines and has appeared on financial television programs as well as network news programs. He has provided financial consulting and expert witness testimony on financial and securities matters in Federal and local cases. He received a B.A. in Political Science and Economics from Queens College, and M.B.A. in Finance and Investments from Baruch College of the City University of New York.

For more information, visit www.mdsass.com


Schroder Ventures

       Nick Somers, Partner, Schroder Ventures

      Nick Somers, Partner, joined Schroder Ventures in 1998. He has been in private equity since 1993 and investment banking since 1987. Nick has completed numerous buy-and-build strategies in the media and telecommunications industries as well as investments in technology growth-oriented areas. Nick serves on the boards of Mesa Communications and ThoughtWorks. Prior to Schroder Ventures, Nick was a founder and partner of Greenwich Street Capital Partners, the private equity affiliate of The Travelers. Nick was also with Morgan Stanley as one of the senior members of the Financial Buyers Group. He began his business career at Chemical Bank. Nick received an MBA degree from the University of Chicago and a BA degree from Washington University in St. Louis.

      Schroder Venture Partners LLC ("Schroder Ventures US" or "SVUS") is one of six affiliated international private equity organizations advising over $7.5 billion of funds under management in 11 offices located in North America, Europe, and Asia. SVUS is focused on middle market investment opportunities in the media, business services, communications and technology sectors in partnership with management. Current investments include Mesa Communications. Group LLC, a wireless tower operator, ThoughtWorks, Inc., a custom software development company, and Memec, a global specialty semiconductor distributor. 

For more information, visit www.svus.com
 
        
Moderator:

Davies Ward Phillips & Vineberg

      
William M. Ainley, Partner, Davies Ward Phillips & Vineberg

       Bill Ainley was educated at Cambridge University where he received his B.A. in 1976, his LL.B. in 1977 and his M.A. in 1980 and at McGill University where he received an LL.B. and B.C.L. in 1979. He articled at Davies and was called to the Ontario Bar in 1981. He became a partner at the firm in 1983.  Bill's practice covers a wide range of transactional work with particular emphasis on mergers & acquisitions, securities and corporate finance and private equity.  In mergers & acquisitions, Bill has acted as lead counsel in numerous public tender offers, domestic and cross-border, for both bidders and targets. In the corporate finance area, Bill has acted as lead counsel in numerous complex public financings, including north and south bound cross-border financings, structured financings, and major project financings. Bill's other principal area of practice is private equity where he has represented numerous US and Canadian private equity groups, merchant banks and pension funds in structuring and executing their acquisitions, financings, restructurings and exits. Illustrative clients include Ontario Teachers' Pension Plan Board, Scotia Merchant Corporation, Onex Corporation, AEA Investors and Thayer Capital Partners. Bill is a member of the Editorial Board of Carswell's Canadian Corporation Precedents and Canadian Securities Law Precedents. He has lectured at the University of Toronto and Osgoode Hall Law Schools and has delivered numerous papers at securities law, mergers and acquisitions and finance conferences. Bill was seconded in 1984 to the Ontario Securities Commission as legal adviser to the Chairman. While at the Commission, he was primarily involved in the legislative reforms that created the current take-over and issuer bid rules in Ontario and opened up the ownership rules of the securities industry in Ontario. In 1986, Bill was invited to join the Securities Advisory Committee to the Ontario Securities Commission and served as Chairman of that committee in 1989 and 1990.

      Bill is recognized annually in the Canadian Legal LEXPERT Directory.  He is repeatedly included in LEXPERT/American Lawyer's Leading 500 Lawyers in Canada, and Euromoney's Guide to the World's Leading Mergers & Acquisitions Lawyers and Guide to the World's Leading Capital Market Lawyers. Bill has been recommended in the 2000-2001, 2001-2002, and 2002-2003 editions of Chambers Global's The World's Leading Lawyers as most frequently recommended in the corporate finance, mergers & acquisitions and project finance areas. He is cited as a leading individual in Canadian Corporate/M&A law in the IFLR 1000's The Guide to the World's Leading International Business Law Firms. Bill has been awarded the Martindale-Hubbell Law Directory’s highest accolade, an AV rating.


For more information, visit www.dwpv.com